Levothyroxine Infusion Does Not Increase Heart Transplants Versus Saline Infusion

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 30, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Nov. 30, 2023 -- Intravenous levothyroxine infusion does not result in more hearts being transplanted than saline infusion among hemodynamically unstable brain-dead potential heart donors, according to a study published in the Nov. 30 issue of the New England Journal of Medicine.

Rajat Dhar, M.D., from the Washington University School of Medicine in St. Louis, and colleagues randomly assigned 838 hemodynamically unstable potential heart donors within 24 hours after declaration of death according to neurologic criteria to open-label infusion of intravenous levothyroxine or saline placebo (419 to each) in a trial involving 15 U.S. organ-procurement organizations.

Hearts were transplanted from 230 and 223 donors (54.9 and 53.2 percent) in the levothyroxine and saline groups, respectively (adjusted risk ratio, 1.01; 95 percent confidence interval, 0.97 to 1.07; P = 0.57). The researchers found that graft survival at 30 days occurred in 97.4 and 95.5 percent of hearts transplanted from donors assigned to receive levothyroxine and saline, respectively (difference, 1.9 percentage points; 95 percent confidence interval, −2.3 to 6.0; P < 0.001 for noninferiority). No substantial differences were seen between the groups in weaning from vasopressor therapy, ejection fraction on echocardiography, or organs transplanted per donor; there were more cases of severe hypertension and tachycardia in the levothyroxine versus the saline group.

"We found no significant benefit of intravenous levothyroxine treatment on improving donor heart utilization," the authors write.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords